14/08/25 08:38:33

Foreign stocks: Many tech stocks – and the topic of rare soils

Many US tech stocks are climbing to new highs, with US software provider Palantir even seeing its share price increase tenfold since the beginning of 2024. Sales of shares in key metals, such as rare soils, have picked up.

14 August 2025. FRANKFURT (Börse Frankfurt). Nvidia, Microsoft, Amazon – US tech stocks continue to dominate foreign stock trading on the Frankfurt Stock Exchange. Nvidia (US67066G1040) was once again the top performer in July. The stock has just reached a new all-time high of €160.58 in Germany. The top 20 also includes five other members of the Magnificent Seven, namely Microsoft, Amazon, Apple, Alphabet (US02079K3059) and Tesla – only Meta is missing. Also high up the list are Danish weight loss injection manufacturer Novo-Nordisk, Chinese carmaker BYD (CNE100000296), Korean semiconductor manufacturer SK Hynix, US software provider Palantir (US69608A1088) and crypto trading platform Coinbase (US19260Q1076).
 

“If you're not afraid of AI chatbots, you can buy Alphabet.”

While Alphabet's Nasdaq price is approaching its all-time high from February again, it is still a long way from its record high of just under 199 euros, currently trading at 172 euros (US02079K3059). Torsten Tiedt from the stock platform aktienfinder.net does not consider the stock to be too expensive: “With a P/E ratio of 18, Alphabet is cheaply valued compared to Amazon at 26 or Microsoft at 36,” he explains. Many feared that the triumph of AI chatbots would come at the expense of Alphabet's advertising revenue. However, the latest quarterly figures tell a different story. “Advertising revenue increased by 12 percent, and the cloud business by 32 percent,” notes Tiedt. “Those who are not afraid of AI chatbots can take advantage of this opportunity.”

Torsten Tiedt

“Palantir extremely highly valued”

The share price of the controversial US analytics software provider Palantir (“US espionage programs”) has climbed to new heights. On the Deutsche Börse marketplaces, Palantir (US69608A1088) was still trading at €15 at the beginning of 2024, but now stands at €158 – more than a tenfold increase in just over a year and a half. “The demand for information and analysis, even from governments, is high in uncertain times, and with average revenue growth of 50 percent over the last five years, Palantir is one of the biggest beneficiaries,” reports Tiedt. However, shareholders should be cautious. With a P/E ratio of 345 based on adjusted earnings, the stock is extremely highly valued.

Mitsubishi Heavy benefits from trade agreement

Global trade policy is also an important driver of foreign stock trading on the Frankfurt Stock Exchange, as Marc Richter of Steubing AG notes. “Japan recently signed a trade agreement with US President Trump, and the US and China have again postponed their mutual tariffs for 90 days,” the trader remarks. “This suggests a deliberate rapprochement on both sides.” According to Richter, Mitsubishi Heavy Industries (JP3900000005) is one of the companies benefiting from the agreement with Japan. “The heavy machinery company, which manufactures ships, aircraft, and engines for commercial and military use, has grown by almost 80 percent over the course of the year,” reports the trader. 
 

Marc Richter

Rare soils: “Agreement extremely important”

The rare soils and other important metals sector is also strongly influenced by trade policy and tariffs. “We have two stocks with real jumps in sales,” explains Richter, referring to Rainbow Rare Earths (GG00BD59ZW98) and Guardian Metal Resources (GB00BPQY8R36). Since China has a virtual monopoly on the exploration of rare earths, a trade agreement between the US and China is extremely important. Rainbow Rare Earths is involved in the development of rare earth projects in South Africa and Burundi, while Guardian Metal mines tungsten and lithium, among other metals that are also very important. 

Novo-Nordisk: “A definite buy”

Novo-Nordisk is on the losing side. The share price had risen rapidly to almost €140 by last summer, but now stands at just €44. “Competition from Eli Lilly and prescription weight-loss drugs on a large scale in the US are causing problems for the company,” explains Tiedt. Nevertheless, Novo-Nordisk remains on course for growth, with profits expected to rise by 13 percent in the current fiscal year. “With a P/E ratio of 13 and a dividend yield of 3.6 percent, Novo-Nordisk shares are a clear buy for us.”

By Anna-Maria Borse, 14 August 2025, © Deutsche Börse AG

Anna-Maria Borse is a financial and business editor specializing in financial markets/stock exchanges and economic issues.

Feedback and questions to redaktion@deutsche-boerse.com